To study the involvement of DNA mismatch-repair genes in sporadic breast cancer, matched normal and tumoral DNA samples of 22 patients were analysed for genetic instability and loss of heterozygosity (LOH) with 42 microsatellites at or linked to hMLH1 (3p21), hMSH2 (2p16), hMSH3 (5q11-q13), hMSH6 (2p16), hPMS1 (2q32) and hPMS2 (7p22) loci. Chromosomal regions 3p21 and 5q11-q13 were found hemizygously deleted in 46% and 23% of patients respectively. Half of the patients deleted at hMLH1 were also deleted at hMSH3. The shortest regions of overlapping (SRO) deletions were delimited by markers D3S1298 and D3S1266 at 3p21 and by D5S647 and D5S418 at 5q11-q13. Currently, the genes hMLH1 (3p21) and hMSH3 (5q11-q13) are the only known candidates located within these regions. The consequence of these allelic losses is still unclear because none of the breast cancers examined displayed microsatellite instability, a hallmark of mismatch-repair defect during replication error correction. We suggest that hMLH1 and hMSH3 could be involved in breast tumorigenesis through cellular functions other than replication error correction.
Breast cancer is the most frequent neoplasia that affects women in the Western world. It is a heterogeneous disease, which displays a broad spectrum of clinical and pathological characteristics, and like most solid tumours is thought to develop through the accumulation of genetic alterations leading to uncontrolled cellular growth. Loss of heterozygosity (LOH) studies in non-hereditary breast tumours have shown deletions at a frequency ranging from 20% to 50% in several chromosomal arms (reviewed in Sato et al, 1990; Cornelisse et al, 1992; Bi•che and Lidereau, 1995) , suggesting the involvement of several tumour-suppressor genes in breast carcinogenesis.
Recently, another type of gene, encoding components of the DNA mismatch-repair system, has been linked to hereditary non-polyposis colorectal cancer (HNPCC) (Fishel et al, 1993; Leach et al, 1993; Bronner et al, 1994; Nicolaides et al, 1994; Papadopoulos et al, 1994 Papadopoulos et al, , 1995 . These genes have been found mutated in HNPCC and are presumably involved in certain sporadic forms of cancer (Leach et al, 1993; Nicolaides et al, 1994; Papadopoulos et al, 1994 Papadopoulos et al, , 1995 Liu et al, 1995; Risinger et al, 1996) . Their defects generally lead to a genome-wide instability of microsatellites in tumoral cells referred to as the replication error (RER) phenotype. In addition to HNPCC, the RER phenotype was observed in a number of sporadic cancers (Han et al, 1993; Speicher, 1995) including breast cancer (Yee et al, 1994; Karnik et al, 1995; Paulson et al, 1996) , thus suggesting that deficiency in DNA repair could be involved in breast carcinogenesis. Like suppressor genes (Knudson, 1971) , mismatch-repair mutants are inherited as recessive traits that eventually become dominant because of somatic mutations inactivating the second allele. This second mutational step may be revealed as LOH which was reported at the hMLH1 locus in HNPCC patients (Hemminki et al, 1994) as well as in sporadic colorectal cancers (Tomlinson et al, 1996) .
Based on these observations, we examined the involvement of mismatch-repair genes in sporadic breast cancer by microsatellite instability and LOH analyses. We have screened 22 primary breast carcinomas using 42 polymorphic microsatellites within or closely linked to hMLH1, hMSH2, hMSH3, hMSH6, hPMS1 and hPMS2 loci. We found that hMLH1 and hMSH3 were frequently deleted in tumoral cells, suggesting their possible involvement in sporadic breast cancer.
MATERIALS AND METHODS

DNA samples
Matched tumoral and normal sample pairs were obtained from 22 breast carcinoma patients (ages 40Ð90; mean, 58.09; median, 60), including ten metastatic cases, who underwent surgery at the Montreal H™tel-Dieu Hospital. This is an unselected group of apparent sporadic cases with limited clinical information. Because family histories were unavailable, it was expected that, if any, only 5Ð10% of the samples would be from patients with a familial form of the disease (Newman et al, 1988) . DNA was isolated from fresh material by a standard procedure using digestion with proteinase K and phenol/chloroform extractions. 
Microsatellite analysis
Matched DNA sample pairs were genotyped by polymerase chain reaction (PCR) at the 42 following highly polymorphic (62Ð90% heterozygosity) microsatellite loci: on chromosome 3p14Ðp26 (hMLH1), D3S1286, D3S1266, D3S1745, D3S1561, D3S1611, D3S1612, D3S1298, D3S1260, D3S3559, D3S3582, D3S3647, D3S1588, D3S1582, D3S1613, D3S1234, D3S1300 and D3S1312; on 5p14Ðq21 (hMSH3), D5S416, D5S477, D5S651, D5S674, D5S426, D5S395, D5S418, D5S430, D5S491, D5S398, D5S431, D5S624, D5S427, D5S668, D5S647, D5S629, D5S428 and D5S433; on 2q32 (hPMS1) , D2S318 and D2S118; on 2p16 (hMSH2/hMSH6), D2S391 and D2S288; on 7p22 (hPMS2), D7S531 and D7S517. The corresponding PCR primers were provided by Research Genetics. The chromosomal assignment of these microsatellites and genes was performed by integrating genetic, radiation hybrid and STS/YAC data from several sources (Gyapay et al, 1994; Hudson et al, 1995; Gemmill et al, 1995) . Thirty amplification cycles of 1 min at 94°C, 1 min at 50Ð60°C and 1 min at 72°C were carried out in 20 µl of 10 mM tris-HCl (pH 8.3), 50 mM potassium chloride, 1.5 mM magnesium chloride containing 0.2 µM of each primer, 50 µM dNTPs, 1 µCi of [ 32 P]αCTP (ICN; specific activity 3000 Ci mmol Ð1 ), 5 ng of genomic DNA, and 0.4 U Taq DNA polymerase (BRL). The products were fractionated by denaturing electrophoresis in a 6% polyacrylamide gel, subsequently dried and autoradiographed. LOH was defined visually as the disappearance or significant reduction in the intensity of one allele in tumoral DNA compared with the normal DNA sample as described in Baccichet et al (1997) . Only informative (heterozygous) loci were considered for LOH frequency calculations.
Single-strand conformational polymorphism (SSCP) analysis
The typing of hMLH1 exon 8 polymorphism by SSCP analysis using previously published oligonucleotides (Han et al, 1995) was performed as described in Zietkiewicz et al (1992) .
RESULTS
Our microsatellite analysis ( Figure 1 ) revealed LOH in 10 out of the 22 patients in at least one of the mismatch-repair loci tested (Table 1) .
Detection of LOH on chromosome 3p21
Out of the 22 patients, ten (46%) exhibited LOH in at least one of the microsatellite markers located on chromosome 3p21. Patient 3 lost an allele at D3S1745 and D3S1561, but maintained heterozygosity at the distal neighbouring locus D3S1266; patient 43 showed LOH at every marker distal to D3S1611 and D3S1612, but retained both alleles at D3S1298 (Figure 2 ). These results suggested that the shortest region of overlapping (SRO) deletions delimited by D3S1298 and D3S1266 included hMLH1 at 3p21Ðp22 ( Figure 2 ). In addition to the intragenic D3S1611 marker , we analysed by SSCP a biallelic polymorphism in exon 8 of hMLH1 to show hemizygous deletion in the three informative cases (not shown).
Several genes have been shown to be included in LOH regions on chromosome 3p (Figure 2 ). We extended the allelotyping to investigate the possible involvement of the SCLC region, which was shown to be homozygously deleted in small-cell lung cancer cell lines (Daly et al, 1993) , as well as the FHIT and PTPRG genes ( Figure 2 ). Among the ten patients with LOH at hMLH1, four retained heterozygosity at proximal markers ( Figure 2 ). For instance, in patient 11, markers D3S1298 through D3S1286 revealed LOH, but at markers proximal to D3S1260 both alleles were retained thus excluding the SCLC region as well as FHIT and PTPRG as deletion targets. Similarly, these loci were excluded from the SRO in patient 43 (Figure 2 ). The SCLC region delimited by markers D3S1588 and D3S1613 (Daly et al, 1993) was partly affected by LOH in patients 3 and 29. Particular attention was placed on FHIT because abnormal transcription of this gene was reported in 30% of breast cancer patients (Negrini et al, 1996) . Markers linked to the FHIT locus, including D3S1300 which maps within intron 5 of the FHIT gene (Man et al, 1996) , were deleted in 4 out of the 11 cases informative at this locus (36%), which were all also deleted for hMLH1 (not shown). Therefore, 3p deletions represent two groups, one with small deletions affecting the hMLH1 locus and another with larger deletions that include the hMLH1, SCLC and FHIT loci (Figure 2 ).
Detection of LOH on chromosome 5q11-q13
As shown in Figure 3 , 5 out of the 22 informative cases (23%) were hemizygously deleted at one or more marker loci tightly linked to the hMSH3 locus. All of these patients with LOH at 5q11Ðq13 were also deleted in the 3p21 region (Figure 2 and 3 ). This non-random distribution of concomitant deletions was statistically significant (P 0.02, chi-squared test). Large deletions were seen in patients 9 and 37, whereas others exhibited restricted LOH: patient 13 with LOH at D5S430 retained heterozygosity at every marker proximal to D5S418, whereas patient 29 was heterozygous at D5S647 thus delimiting the SRO between D5S418 and D5S647 at 5q11Ðq13 (Figure 3 ). The tumour-suppressor genes APC and MCC both located on chromosome 5q21 were excluded from deletions involving hMSH3 in two of the patients (13 and 29) heterozygous for markers linked to APC and MCC regions (Figure 3) . Thus, hMSH3 is a good candidate as the target of 5q11Ðq13 deletions.
In contrast to hMLH1 and hMSH3, we found only two patients that were affected by allelic deletions at other tested loci: 1 out of 21 informative cases at hPMS2, 1 out of 20 at hMSH2/hMSH6 and 2 out of 20 at hPMS1 (Table 1) , including patient 9 who displayed LOH at all investigated loci. The low rate of allelic losses (5Ð10%) affecting the chromosomes 2p16, 2q31Ðq33 and 7p15Ðpter may reflect the baseline frequency of LOH in breast cancer (Chen et al, 1992) .
Microsatellite instability
None of the 22 tumours displayed the RER phenotype as judged by the absence of instability at the 42 microsatellites tested (a total of 572 independent comparisons). Although our markers were already shown as sensitive to detecting RER in sporadic colorectal cancers (Benachenhou et al, 1998a) , we additionally examined two markers GGAA4D07 and GGAA2E02 recently reported as unstable in 30% (11 out of 37) and 41% (15 out of 37) of breast cancer patients respectively (Paulson et al, 1996) . These two markers did not reveal any instability in the 22 tumours examined here (data not shown). Our findings were thus consistent with studies of two large cohorts of breast cancer patients that failed to detect significant levels of microsatellite instability (Lothe et al, 1993; Wooster et al, 1994) . 
DISCUSSION
The activation of oncogenes, the loss or inactivation of repressor genes and impaired mismatch-repair function are known to be involved in the development of solid tumours. Defects in DNA mismatch-repair genes lead to replication errors revealed as instability in microsatellite markers (Leach et al, 1993; Bronner et al, 1994; Papadopoulos et al, 1994) . A proposal that deficient DNA repair was a predisposing factor in sporadic breast cancer (Helzlsouer et al, 1996; Parshad et al, 1996) was promoted by reports of microsatellite instability in breast tumours (Yee et al, 1994; Karnik et al, 1995; Paulson et al, 1996) . By allelotyping the mismatch-repair genes hMLH1, hMSH2, hMSH3, hMSH6, hPMS1 and hPMS2, we have shown that 46% and 23% of the breast tumours tested were affected by allelic losses at hMLH1 and hMSH3 respectively. Because none of the tumour tissues were microdissected, these figures should be considered conservative as some allelic losses could have been masked by contaminating genetic material of normal cells. Other alterations such as small deletions, point mutations, gene rearrangements, or DNA methylation, if they also contribute to inactivation of these loci, could escape detection by our approach. Further studies are required to explore these possibilities. Interstitial deletion of chromosome 3p is one of the most common genetic rearrangements observed in tumour cells (Pandis et al, 1993) . The region 3p14Ðp23 has been shown to be deleted in small-cell lung carcinomas (Petersen et al, 1997) , non-small-cell lung carcinomas (Benachenhou et al, 1998b ) renal cell carcinomas (Foster et al, 1994) and uterine cervical carcinomas (Kohno et al, 1993) . In breast cancer, LOH ranging from 30% to 47% were observed at two separate regions, 3p13Ðp14 and 3p21Ðp25 (Chen et al, 1994) or 3p14.3Ðp21.1 and 3p24.3Ðp25.1 (Matsumoto et al, 1997) , suggesting the involvement of several tumour-suppressor genes. PTPRG, a protein-tyrosine phosphatase gene, and FHIT that encodes the human diadenosine triphosphate hydrolase (Barnes et al, 1996) , both localized within the 3p13Ðp14 region, are potential candidates as targets of deletions in primary breast tumours (LaForgia et al, 1991; Negrini et al, 1996; Ohta et al, 1996) . Furthermore, a 3p21.3 region (SCLC) was shown to be homozygously deleted in SCLC cell lines (Daly et al, 1993) . Our allelotyping data narrow down the critically deleted region on chromosome 3p21 (Figure 2 ) to an interval delimited by markers D3S1298 and D3S1266, thus excluding SCLC, FHIT and PTPRG from the SRO (Figure 2) . In another study, we showed that the smallest region of overlapping deletions in non-small-cell lung cancer patients was refined to a 1-cM interval between markers D3S1561 and D3S1612 (Benachenhou et al, 1998b ). The only known candidate which remains in the deleted region is thus hMLH1. Do hemizygous deletions of this gene promote cancer progression, or is hMLH1 only in linkage to a yet unidentified tumour-suppressor gene needs to be investigated further?
Deletions of chromosome 5q were previously reported in several tumour types, including colorectal cancers (Solomon et al, 1987; Vogelstein et al, 1988; Ashton-Rickart et al, 1991) , lung cancers (Ashton-Rickart et al, 1991; DÕAmico et al, 1992; Benachenhou et al, 1998b) , and oesophageal cancers (Boynton et al, 1992) . At least two known tumour suppressors, APC and MCC, are localized within this region. Reports of 5q21 deletions in 18Ð29% of sporadic breast cancers suggests the involvement of APC and MCC (Thompson et al, 1993; Medeiros et al, 1994) . Although some deletions on 5q overlap with the APC/MCC region, our results exclude these loci from the SRO in 40% of the 5q deleted patients. Delimited by D5S418 and D5S647, this SRO is 43.5 cM away from APC and MCC (Figure 3) . Allelic losses at 5q13.1Ðq21 in 33% of ovarian cancers (Tavassoli et al, 1996) as well as in 42% of NSCLC (Benachenhou et al, 1998b ) also occurred outside the APC-containing region. Thus, genes other than APC/MCC have to be considered as targets of 5q11Ðq13 deletions. hMSH3 is a good candidate as the target of 5q11Ðq13 deletions, although the existence of a yet unidentified adjacent gene cannot be ruled out.
None of the tumors analysed in this study displayed microsatellite instability, a hallmark of a deficiency in the replication errors correction. Expecting a 30% incidence of instability as reported by Paulson et al (1996) , the probability of not detecting a single unstable tumour in our sample of 22 was as low as 0.0014 (Po = e Ð0.3 × 22 ). The absence of RER is, however, consistent with earlier reports indicating a virtual absence of microsatellite instability in breast tumour cells (Han et al, 1993; Lothe et al, 1993; Wooster et al, 1994) . Moreover, considering four studies (Han et al, 1993; Lothe et al, 1993; Wooster et al, 1994 ; this study) in which no evidence of RER was obtained (i.e. no more than a single instability per sample), we estimated the average rate of somatic microsatellite mutations at 5 × 10 Ð3 (12 out of 2556), a frequency similar to the one from T-lymphocytes (3 × 10 Ð3 ) (Hackman et al, 1995) . It is difficult to explain the variability in the reported prevalence of RER+ breast tumours ranging from 0% to 30%. Because the random sampling effect was rather unlikely, this discrepancy could be related to sample stratification, to criteria used to define RER+ tumours (Dietmaier et al, 1997) and the nature of the markers used to reveal this phenotype (Arzimanoglou et al, 1998) , or requires other explanations.
We are, thus, left with patients associated with hemizygous deletions at two mismatch-repair loci and no RER. If the nondeleted hMLH1 and hMSH3 alleles are still active, this could explain the absence of a RER phenotype. At this point, it is difficult to decide whether hemizygous deletions of hMLH1 and hMSH3 genes promote breast tumorigenesis, or whether LOH at these loci only indicates linkage with as yet unknown tumoursuppressor loci. However, concomitant deletions of hMSH3 and hMLH1 in a number of patients raise unanswered questions about their relationship. hMSH2 and hMSH6 or hMSH3 proteins bind the mismatch as heterodimers called, respectively, hMutSα and hMutSβ (Drummond et al, 1995; Palombo et al, 1996) , which are then recognized by the heterodimer hMutLα composed of hMLH1/hPMS2. Therefore, a gene dosage effect affecting the stoichiometry and the activity of the heteromolecular mismatch-repair complex may be sufficient to promote cancer by impairing functions other than the correction of replication errors. Mismatchrepair proteins are involved in a variety of vital cellular processes, including the homologous recombination (Jones et al, 1987; deWind et al, 1995) , the mediation of the G2 checkpoint (Hawn et al, 1995) , transcription-coupled nucleotide excision repair (Mellon et al, 1996) and in the recognition of DNA damage and/or in the signalling pathway contributing to the generation of apoptotic cells (Kat et al, 1993; Mu et al, 1997) . Interestingly, the influence of environmental factors on the genome stability in cells defective in nucleotide excision repair and mismatch-repair could be substantial. In this regard, it has been recently demonstrated that homozygous as well as heterozygous hMSH2 mutant mammalian cells have a propensity to accumulate potentially mutagenic oxidative DNA damage (DeWeese et al, 1997 ) that may promote the development of cancer through defects in genes sensitive to exogenous factors (Mellon et al, 1996; DeWeese et al, 1997) . In addition, a heterozygous mutation in hMLH1 in a human-derived cancer cell line was shown to significantly reduce transcription-coupled repair involved in selective removal of DNA damage from the transcribed strands of active genes (Mellon et al, 1996b) , pointing to the possibility that allelic deletion of hMLH1 and/or hMSH3 could have the same effect. We propose that a subtle defect in the repair of DNA damage, which is less likely to be lethal to the carrying cells, could have an even more profound impact on tumorigenesis, thus placing individuals at increased cancer risk.
In conclusion, our allelotyping analysis of sporadic breast carcinomas demonstrated that two DNA mismatch-repair loci, hMLH1 and hMSH3, are frequently affected by LOH at chromosomal regions 3p21 and 5q11Ðq13 respectively. We suggest that hMLH1 and hMSH3 deletion could promote cancer progression through a dosage effect affecting cellular functions other than replication errors correction. Whether or not hMLH1 and hMSH3 are real targets of the deletions is still under investigation, but the identification of genes with suppressor activity for malignancy at 3p21 and 5q11Ðq13 is extremely important considering the frequency of LOH at these regions in several major forms of cancer.
